CT1-3 is a potent anti-cancer agent. CT1-3 regulates the JNK/Bcl-2/Bax/XIAP pathway, which induces mitochondria-mediated apoptosis. CT1-3 regulates the E-cadherin/Snail axis to inhibit epithelial mesenchymal transition (EMT) potentials in human cancer cells (HCCs) and suppresses tumourigenesis. CT1-3 has anti-tumour effects in mouse models and does not show significant hepatotoxicity or nephrotoxicity.
Molecular Weight:
455.63
CAS Number:
[2460738-32-1]
Formula:
C25H29NO3S2
Target:
Others|||Bcl-2 Family|||Apoptosis|||JNK
T62822
* VAT and and shipping costs not included. Errors and price changes excepted